Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310905![]() (2-methyl-7-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310911![]() (6-methyl-4-(2-methyl-3,4-dihydro-1H-isoquinolin-6-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310910![]() (4-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)-N...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 75 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310909![]() (4-[4-(3,3-difluoroazetidine-1-carbonyl)phenyl]-6-m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310912![]() (3-(2,6-dimethyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310904![]() (3-methoxy-N-[4-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310908![]() (6-methyl-4-(4-(4-methyl-3-oxopiperazine-1-carbonyl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310906![]() (N,N-dimethyl-4-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 730 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310907![]() (3-(6-ethyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair |